-
公开(公告)号:DE19650975A1
公开(公告)日:1998-06-10
申请号:DE19650975
申请日:1996-12-09
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , MOELLER ACHIM DR , TREIBER HANS-JOERG DR
IPC: A61K31/403 , A61K31/4035 , A61K31/405 , A61K31/4439 , A61K31/496 , A61K31/517 , A61K31/519 , A61K31/5377 , A61P9/00 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P35/00 , A61P35/04 , A61P43/00 , C07D209/48 , C07D209/66 , C07D239/70 , C07D239/96 , C07D401/12 , C07D471/04 , C07D475/02 , C07D235/26 , C07D235/02 , C07D217/24 , C07D209/64 , C07D275/06 , C07D403/12 , A61K31/40 , A61K31/505
Abstract: The invention concerns heterocyclically substituted benzamides of formula (I) in which R , R , R , R , R , X, m and n have the meanings given in the description. The novel compounds are suitable for fighting diseases.
-
公开(公告)号:DE19624808A1
公开(公告)日:1998-01-02
申请号:DE19624808
申请日:1996-06-21
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , BEHL BERTHOLD DR , HOFMANN HANS-PETER DR , SZABO LASZLO DR
IPC: C07D403/04 , A61K31/495
Abstract: Pyrrolyl quinoxalindiones of formula (I) and their tautomeric and isomeric forms and their physiologically acceptable salts, in which R is hydrogen, C1-C6 alkyl, substituted by hydroxyl or carboxyl, R is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, a chlorine, fluorine or bromine atom, a trihalogen methyl, cyano, or nitro group or SO2C1C4 alkyl, R is COOH or a radical hydrolysable to form the carboxyl group, and n is 1 or 2.
-
公开(公告)号:DE59102245D1
公开(公告)日:1994-08-25
申请号:DE59102245
申请日:1991-10-04
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BINDER RUDOLF DR , RASCHACK MANFRED DR , REINHARDT ROLAND DR , SEEMANN DIETMAR DR
IPC: A61K31/445 , A61K31/4427 , A61K31/4468 , A61P9/00 , C07D211/58 , C07D401/12
Abstract: Phenylpiperidylamines of the formula I I R1 is H, NO2, R4SO2NH, N=C, CF3, CF3O, F, Cl, Br, C1-C4-alkyl, R3O, CO2R3, CHO, CH=NOR3, CH3OR3 and R2 is H, F, Cl, Br, C1-C4-alkyl or R4O, where R1 and R2 are not both H, R3 is H or R4, R4 is C1-C4-alkyl or phenyl, n is 1, 2, 3 or 4 and Ar is and the physiologically tolerated salts thereof, are used as active ingredients in drugs.
-
公开(公告)号:DE4036782A1
公开(公告)日:1992-05-21
申请号:DE4036782
申请日:1990-11-17
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , PHILIPSBORN GERDA VON DR MED , SCHULT SABINE DR , KIRCHENGAST MICHAEL DR
IPC: A61K31/165 , A61K31/00 , A61K31/16 , A61K31/167 , A61K31/40 , A61K31/445 , A61K31/4453 , A61P9/00 , A61P9/06 , C07C233/29 , C07C235/38 , C07D295/08 , C07D295/088 , C07D295/092
Abstract: Substituted anilides of the formula I I (where R1 is C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, halogen, cyano, nitro, C2-C4-alkenyl, C2-C4-alkynyl; X is methylene, ethylene, vinylene; R2 and R3 are each C1-C4-alkyl, C3-C6-cycloalkyl or together are tetra- or pentamethylene; R4 is C1-C4-alkyl, methoxy; n is 2, 3 or 4), and the physiologically tolerated acid addition salts thereof, the pharmaceutical use thereof, drugs produced therefrom and the use thereof for treating cardiac arrhythmias and/or for lowering the heart rate, are described.
-
公开(公告)号:DE3825559A1
公开(公告)日:1990-02-01
申请号:DE3825559
申请日:1988-07-28
Applicant: BASF AG
IPC: A61K31/135 , A61K31/13 , A61K31/395 , A61K31/40 , A61K31/445 , A61P9/06 , C07C217/22 , C07D295/08 , C07D295/092
Abstract: p-Hydroxyphenone derivatives of the general formula I … … in which R , R and R are identical or different and are methyl, chlorine, bromine and hydrogen, where R , R and R are not all H, R and R are identical or different and are H, C1-C4-alkyl or OR , where R and R are not both H, X is a -CH=CH-, -CH2CH2- and -CH2-bridge, Y is a straight-chain or branched, saturated or unsaturated C1-C4-bridge and Z is the radical NR R , where R and R are, independently of one another, hydrogen or C1-C4-alkyl, or Z is a 5- or 6-membered ring with a nitrogen atom in position 1 and, where appropriate, additionally a second N or an O or S atom, where the second N atom is substituted by R , the physiologically tolerated salts thereof, and medicaments prepared therefrom and the use thereof as Vaughan-Williams Class III antiarrhythmic.
-
公开(公告)号:AT172461T
公开(公告)日:1998-11-15
申请号:AT93107984
申请日:1993-05-17
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , BEHL BERTHOLD DR , HOFMANN HANS PETER DR
IPC: A61K31/495 , A61K31/498 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/26 , C07D241/44 , C07D241/52 , C07D401/04 , C07D403/04 , C07D487/12 , C07D487/14
Abstract: Quinoxaline-2,3-(1H,4H)diones of the general formula I in which the variables have the following meaning: R is hydrogen; an aliphatic radical having up to 12 C atoms, which can carry one of the following substituents: phenyl, cyclopentyl, cyclohexyl or a group -CO-R , -CO-O-R or -CO-NH-R , where R denotes hydrogen, C1-C4-alkyl, phenyl, benzyl or 1-phenylethyl; a cycloaliphatic radical having up to 12 C atoms, or a phenyl group, where the cyclic groups contained in R can carry up to three of the following substituents: C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, halogen, nitro, cyano, -CO-O-R and -CO-NH-R ; R is a pyrrol-1-yl group which can carry up to two of the following substituents: C1-C4-alkyl, phenyl, phenylsulphonyl, nitro, cyano and one of the groups -CO-O-R , -CO-NH-R , -CH2-O-R , -O-R and -CH=NO-R ; R is identical or different radicals from the following: C1-C4-alkyl, C1-C4-alkoxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, trichloromethoxy, fluorine, chlorine, bromine, iodine, nitro, cyano and one of the groups -CO-O-R and -CO-NH-R and a fused benzene ring; n is 0 to 3. Quinoxaline-2,3-(1H,4H)diones I' in which R has the meaning mentioned. The compounds I and I' are suitable as medicines for human and veterinary medicine.
-
公开(公告)号:CZ113197A3
公开(公告)日:1998-03-18
申请号:CZ113197
申请日:1995-10-02
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , VIERLING MICHAEL , BEHL BERTHOLD DR , HOFMANN HANS PETER DR
IPC: A61K31/495 , A61P25/00 , A61P43/00 , C07D403/04
Abstract: PCT No. PCT/EP95/03902 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Oct. 2, 1995 PCT Pub. No. WO90/11922 PCT Pub. Date Apr. 25, 1996Pyrrolyltetrahydrobenzoquinoxalinediones of the formula I I and their tautomeric and isomeric forms, and their physiologically tolerated salts, in which the variables have the meanings stated in the description, and the preparation thereof are described. The novel compounds are antagonists of the glutamate receptor subtypes and are thus suitable for controlling various diseases.
-
公开(公告)号:DE19503825A1
公开(公告)日:1996-04-04
申请号:DE19503825
申请日:1995-02-06
Applicant: BASF AG
IPC: C07D487/04 , A61K31/495
Abstract: Imidazoloquinoxalinones have the formula (I), in which R stands for hydrogen, branched or linear C1-5-alkyl or a phenyl, pyridyl or thienyl group possibly substituted by one to two chlorine atoms, a trifluoromethyl, a nitrodioxy or a methylene dioxy group; R stands for hydrogen, C1-5-alkyl or C3-8-dialkylaminoalkyl; R stands for a chlorine or bromine atom, a trifluoromethyl, cyano or nitro group; A stands for a five-membered heterocycle with 1-4 nitrogen atoms or 1-2 nitrogen atoms and one oxygen or sulphur atom possible substituted by R and R ; the radicals R and R , that may be the same or different, stand for hydrogen, C1-5-alkyl, C1-5-hydroxyethyl, phenyl, phenyl substituted by a chlorine atom, a trifluoromethyl or nitro group, -CHO, -COOH, -COO-C1-5-alkyl, -CH2-NR R (in which R = H, C1-5-alkyl, R = H, C1-5-alkyl), -CH2-NH-CO-R (in which R = C1-5-alkyl, phenyl, a phenyl group or an heteroaryl group possibly substituted by a chlorine atom of a nitro or trifluoromethyl group) or -CH2-NHCONHR ; and B stands for a bond or a C1-5-alkylene chain. Also disclosed are the tautomer and isomer forms of these compounds, as well as their physiologically compatible salts. These new substances have good glutamate antagonistic effects and are useful for controlling neurodegenerative diseases.
-
公开(公告)号:DK0481288T3
公开(公告)日:1995-09-11
申请号:DK91116812
申请日:1991-10-02
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BINDER RUDOLF DR , RASCHACK MANFRED DR , REINHARDT ROLAND DR , SEEMANN DIETMAR DR
IPC: A61K31/445 , A61K31/4468 , A61P9/00 , C07D211/58
Abstract: Phenylpiperidinylamines of the formula I I where R1 is -NHSO2R4 or R2 and R3 are each, independently of one another, H or C1-C4-alkyl or together are a (CH2)n chain with n=4 or 5, and R4 is C1-C4-alkyl or phenyl, and the physiologically tolerated salts thereof, and pharmaceutical compositions containing these are described.
-
公开(公告)号:DE58908517D1
公开(公告)日:1994-11-24
申请号:DE58908517
申请日:1989-07-21
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , RASCHACK MANFRED DR , VON PHILIPSBORN GERDA DR
IPC: A61K31/135 , A61K31/13 , A61K31/395 , A61K31/40 , A61K31/445 , A61P9/06 , C07C217/22 , C07D295/08 , C07D295/092
Abstract: p-Hydroxyphenone derivatives of the general formula I … … in which R , R and R are identical or different and are methyl, chlorine, bromine and hydrogen, where R , R and R are not all H, R and R are identical or different and are H, C1-C4-alkyl or OR , where R and R are not both H, X is a -CH=CH-, -CH2CH2- and -CH2-bridge, Y is a straight-chain or branched, saturated or unsaturated C1-C4-bridge and Z is the radical NR R , where R and R are, independently of one another, hydrogen or C1-C4-alkyl, or Z is a 5- or 6-membered ring with a nitrogen atom in position 1 and, where appropriate, additionally a second N or an O or S atom, where the second N atom is substituted by R , the physiologically tolerated salts thereof, and medicaments prepared therefrom and the use thereof as Vaughan-Williams Class III antiarrhythmic.
-
-
-
-
-
-
-
-
-